Enrly Lesions in Experimental Bladder Cancer

Experimental Design and Light Microscopic Findings

Samuel Monroe Cohen, Jerome B. Jacobs, Masayuki Arai, Sonny Lennart Johansson, Gilbert H. Friedell

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

N-14-(5-Nitro-2-furyl)-2-thiazolylfformamide (FANFT) fed to male and female Fischer rats at a dose of 0.2% of the diet induces lesions of the urinary bladder which progress from mild hyperplasia at 2 to 4 weeks, to moderate hyperplasia at 6 to 8 weeks, severe nodular and papillary hyperplasia at 10 to 14 weeks, and microinvasive carcinomas by 25 weeks as observed by light microscopy. Male Fischer rats fed FANFT for 2 or 4 weeks and then maintained on control diet show regression of the bladder lesions within 2 weeks to normal-appearing mucosa which persists through 50 weeks. Rats fed FANFT for 6 weeks show regression of the moderately hyperplastic epithelium to normal within 4 weeks after being placed on control diet which persists through 50 weeks. Rats fed FANFT for 8 or 10 weeks show regression of the hyperplastic bladder epithelium within 2 weeks of receiving control diet, but focal areas of mild hyperplasia are detectable through the 20th week of the experiment. By the 50th week the rats fed FANFT for 8 weeks all had moderate to marked hyperplasia, but the rats fed FANFT for 10 weeks had transitional cell tumors, one of which was invasive through the entire thickness of the bladder wall. The lesions present in rats fed FANFT for 12, 14, or 20 weeks continued to progress to invasive tumors (microinvasive or invasion of muscle) after the rats had been maintained on control diet through 50 weeks. Thus, the hyperplastic lesions developing through 6 weeks of FANFT administration appear to be reversible if FANFT is discontinued, but later lesions appear to be irreversible.

Original languageEnglish (US)
Pages (from-to)2508-2511
Number of pages4
JournalCancer Research
Volume36
StatePublished - Jul 1 1976

Fingerprint

FANFT
Urinary Bladder Neoplasms
Research Design
Light
Hyperplasia
Diet
Urinary Bladder
Inbred F344 Rats
Epithelium
Microscopy
Neoplasms
Mucous Membrane

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Cohen, S. M., Jacobs, J. B., Arai, M., Johansson, S. L., & Friedell, G. H. (1976). Enrly Lesions in Experimental Bladder Cancer: Experimental Design and Light Microscopic Findings. Cancer Research, 36, 2508-2511.

Enrly Lesions in Experimental Bladder Cancer : Experimental Design and Light Microscopic Findings. / Cohen, Samuel Monroe; Jacobs, Jerome B.; Arai, Masayuki; Johansson, Sonny Lennart; Friedell, Gilbert H.

In: Cancer Research, Vol. 36, 01.07.1976, p. 2508-2511.

Research output: Contribution to journalArticle

Cohen, SM, Jacobs, JB, Arai, M, Johansson, SL & Friedell, GH 1976, 'Enrly Lesions in Experimental Bladder Cancer: Experimental Design and Light Microscopic Findings', Cancer Research, vol. 36, pp. 2508-2511.
Cohen, Samuel Monroe ; Jacobs, Jerome B. ; Arai, Masayuki ; Johansson, Sonny Lennart ; Friedell, Gilbert H. / Enrly Lesions in Experimental Bladder Cancer : Experimental Design and Light Microscopic Findings. In: Cancer Research. 1976 ; Vol. 36. pp. 2508-2511.
@article{fc03546ddc564daaaa37022dd43bd72f,
title = "Enrly Lesions in Experimental Bladder Cancer: Experimental Design and Light Microscopic Findings",
abstract = "N-14-(5-Nitro-2-furyl)-2-thiazolylfformamide (FANFT) fed to male and female Fischer rats at a dose of 0.2{\%} of the diet induces lesions of the urinary bladder which progress from mild hyperplasia at 2 to 4 weeks, to moderate hyperplasia at 6 to 8 weeks, severe nodular and papillary hyperplasia at 10 to 14 weeks, and microinvasive carcinomas by 25 weeks as observed by light microscopy. Male Fischer rats fed FANFT for 2 or 4 weeks and then maintained on control diet show regression of the bladder lesions within 2 weeks to normal-appearing mucosa which persists through 50 weeks. Rats fed FANFT for 6 weeks show regression of the moderately hyperplastic epithelium to normal within 4 weeks after being placed on control diet which persists through 50 weeks. Rats fed FANFT for 8 or 10 weeks show regression of the hyperplastic bladder epithelium within 2 weeks of receiving control diet, but focal areas of mild hyperplasia are detectable through the 20th week of the experiment. By the 50th week the rats fed FANFT for 8 weeks all had moderate to marked hyperplasia, but the rats fed FANFT for 10 weeks had transitional cell tumors, one of which was invasive through the entire thickness of the bladder wall. The lesions present in rats fed FANFT for 12, 14, or 20 weeks continued to progress to invasive tumors (microinvasive or invasion of muscle) after the rats had been maintained on control diet through 50 weeks. Thus, the hyperplastic lesions developing through 6 weeks of FANFT administration appear to be reversible if FANFT is discontinued, but later lesions appear to be irreversible.",
author = "Cohen, {Samuel Monroe} and Jacobs, {Jerome B.} and Masayuki Arai and Johansson, {Sonny Lennart} and Friedell, {Gilbert H.}",
year = "1976",
month = "7",
day = "1",
language = "English (US)",
volume = "36",
pages = "2508--2511",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",

}

TY - JOUR

T1 - Enrly Lesions in Experimental Bladder Cancer

T2 - Experimental Design and Light Microscopic Findings

AU - Cohen, Samuel Monroe

AU - Jacobs, Jerome B.

AU - Arai, Masayuki

AU - Johansson, Sonny Lennart

AU - Friedell, Gilbert H.

PY - 1976/7/1

Y1 - 1976/7/1

N2 - N-14-(5-Nitro-2-furyl)-2-thiazolylfformamide (FANFT) fed to male and female Fischer rats at a dose of 0.2% of the diet induces lesions of the urinary bladder which progress from mild hyperplasia at 2 to 4 weeks, to moderate hyperplasia at 6 to 8 weeks, severe nodular and papillary hyperplasia at 10 to 14 weeks, and microinvasive carcinomas by 25 weeks as observed by light microscopy. Male Fischer rats fed FANFT for 2 or 4 weeks and then maintained on control diet show regression of the bladder lesions within 2 weeks to normal-appearing mucosa which persists through 50 weeks. Rats fed FANFT for 6 weeks show regression of the moderately hyperplastic epithelium to normal within 4 weeks after being placed on control diet which persists through 50 weeks. Rats fed FANFT for 8 or 10 weeks show regression of the hyperplastic bladder epithelium within 2 weeks of receiving control diet, but focal areas of mild hyperplasia are detectable through the 20th week of the experiment. By the 50th week the rats fed FANFT for 8 weeks all had moderate to marked hyperplasia, but the rats fed FANFT for 10 weeks had transitional cell tumors, one of which was invasive through the entire thickness of the bladder wall. The lesions present in rats fed FANFT for 12, 14, or 20 weeks continued to progress to invasive tumors (microinvasive or invasion of muscle) after the rats had been maintained on control diet through 50 weeks. Thus, the hyperplastic lesions developing through 6 weeks of FANFT administration appear to be reversible if FANFT is discontinued, but later lesions appear to be irreversible.

AB - N-14-(5-Nitro-2-furyl)-2-thiazolylfformamide (FANFT) fed to male and female Fischer rats at a dose of 0.2% of the diet induces lesions of the urinary bladder which progress from mild hyperplasia at 2 to 4 weeks, to moderate hyperplasia at 6 to 8 weeks, severe nodular and papillary hyperplasia at 10 to 14 weeks, and microinvasive carcinomas by 25 weeks as observed by light microscopy. Male Fischer rats fed FANFT for 2 or 4 weeks and then maintained on control diet show regression of the bladder lesions within 2 weeks to normal-appearing mucosa which persists through 50 weeks. Rats fed FANFT for 6 weeks show regression of the moderately hyperplastic epithelium to normal within 4 weeks after being placed on control diet which persists through 50 weeks. Rats fed FANFT for 8 or 10 weeks show regression of the hyperplastic bladder epithelium within 2 weeks of receiving control diet, but focal areas of mild hyperplasia are detectable through the 20th week of the experiment. By the 50th week the rats fed FANFT for 8 weeks all had moderate to marked hyperplasia, but the rats fed FANFT for 10 weeks had transitional cell tumors, one of which was invasive through the entire thickness of the bladder wall. The lesions present in rats fed FANFT for 12, 14, or 20 weeks continued to progress to invasive tumors (microinvasive or invasion of muscle) after the rats had been maintained on control diet through 50 weeks. Thus, the hyperplastic lesions developing through 6 weeks of FANFT administration appear to be reversible if FANFT is discontinued, but later lesions appear to be irreversible.

UR - http://www.scopus.com/inward/record.url?scp=0017063374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017063374&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 2508

EP - 2511

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

ER -